Phreesia faces securities fraud lawsuit
Analysis based on 6 articles · First reported May 19, 2026 · Last updated Jun 01, 2026
The class action lawsuit against Phreesia for alleged securities fraud is likely to negatively impact Phreesia's stock price and investor confidence. Investors who purchased Phreesia's securities during the Class Period may suffer losses, while the The Schall Law Firm stands to gain from representing these investors.
The The Schall Law Firm has initiated a class action lawsuit against Phreesia, a publicly traded company, alleging violations of securities laws. The lawsuit claims that Phreesia made false and misleading statements to investors between May 8, 2025, and March 30, 2026, regarding its long-term growth outlook and fiscal year 2027 revenue projections. Specifically, Phreesia allegedly misrepresented the reliability of its pharmaceutical marketing commitments as a growth driver for its Network Solutions segment, despite inherent uncertainties. Investors who suffered losses during this period are encouraged by Brian Schall of the The Schall Law Firm to join the lawsuit before July 13, 2026, to recover damages.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard